Ofichem

The Ofichem Group manufactures, develops and distributes active pharmaceutical ingredients (APIs) for both the veterinary and human market. These active compounds are distributed worldwide to pharmaceutical producers. The production of APIs is in accordance with the guidelines of Good Manufacturing Practices (GMP). The Ofichem Group also has his own laboratory which doesn’t only analyse the produced APIs, but also analyses APIs for external clients.

Lab Ofichem manufactures active pharmaceutical ingredients (APIs) for both the veterinary and human market. These active compounds are distributed worldwide to pharmaceutical producers. The production of APIs is in accordance with the guidelines of Good Manufacturing Practices (GMP). In addition to production and developing APIs, Lab Ofichem also analyses APIs for external clients.

Ofichem B.V. buys and sells active pharmaceutical ingredients (APIs) for the veterinary market. We have an extensive portfolio of our own-produced and purchased APIs. The components we sell can be analyzed in our laboratory and provided with appropriate documentation.

Ofipharma sells active pharmaceutical ingredients (APIs) for the human market. The compounds we sell can all be tested in our own laboratory and provided with appropriate documentation.

Incopharm trades in active pharmaceutical ingredients (APIs) for the veterinary and human market. The company is fifty percent owned by the Ofichem Group and is based in Hamburg and Moscow. For the sale of APIs Incopharm focuses on eastern Europe, the Baltic states, Belarus and the Russian market.